Latest Conference Articles
The OncLive® Conference page includes a listing of all conferences covered by OncLive®, including the ASCO, ESMO, SITC, EHA, ASH, and SABCS annual meetings, as well as the Chemotherapy Foundation Symposium and Miami Breast Cancer Conference, among many others. Conference coverage incorporates articles and interviews in written and video format.
Patients With Metastatic Kidney Cancer Prefer Pazopanib Over Sunitinib, Study Shows
June 2nd 2012, 6:21am
Study finds that more than two-thirds of patients with metastatic kidney cancer prefer pazopanib over another FDA-approved treatment, sunitinib.
Large Study of ALL Patients Finds Lower Survival in Adolescent and Young Adult Patients
June 2nd 2012, 5:59am
Adolescent and young adult patients between the ages of 16 and 30 had poorer outcomes when given the same treatment regimen as younger acute lymphoblastic leukemia patients.
PD-1 Immunotherapy Makes Strong Showing in Three Tumor Types
June 2nd 2012, 5:39am
An immunotherapy agent that targets the PD-1 pathway demonstrated response rates as high as 28% in an early-phase study involving patients with different tumor types.
Dr. Rotkowitz on BRAF/MEK Combination Side Effects
June 1st 2012, 4:01pm
Dr. Michael Rotkowitz, from Cancer Treatment Centers of America, on Dabrafenib and Trametinib Combination Side Effects
Analysts, Companies Highlight Key ASCO Research
June 1st 2012, 5:00am
Pharmaceutical industry analysts and companies have been weighing in on their selections for the most noteworthy research to be presented during the 2012 ASCO Annual Meeting.
2012 ASCO Pre-Meeting Video Coverage
May 31st 2012, 2:10pm
American Society of Clinical Oncology (ASCO) 2012 Annual Meeting video highlights, from OncLive TV.
Advanced Coverage Recap: 2012 ASCO Annual Meeting
May 30th 2012, 1:51pm
On May 16, the ASCO highlighted the results of five ground-breaking studies in advance of its annual meeting held in Chicago from June 1-5, 2012.
Dr. Goy Highlights Research From the 2012 ASCO Meeting
May 30th 2012, 12:40pm
Dr. Andre Goy, from John Theurer Cancer Center, Highlights Research From the 2012 ASCO Meeting.
Dr. Gomella on the Unique Attributes of Neoadjuvant Zytiga
May 30th 2012, 10:06am
Dr. Leonard Gomella, from Jefferson Kimmel Cancer Center, on the Unique Attributes of Neoadjuvant Zytiga.
Dr. Ladenson on Diagnosis of Thyroid Nodules
May 29th 2012, 12:09pm
AACE Annual Scientific and Clinical Congress
Dr. Paul W. Ladenson, from Johns Hopkins Medicine, on Diagnosis of Thyroid Nodules
Carriers of Mutation Responsible for Multiple Endocrine Neoplasia Can Face Difficult Choices
May 29th 2012, 6:42am
AACE Annual Scientific and Clinical Congress
Results of a multi-generational case study strengthen the case for genetic screening in cases of hereditary thyroid cancer.
Researchers Find Regional Differences in Stage of Presentation and Survival of Individuals With Thyroid Cancer
May 29th 2012, 6:38am
AACE Annual Scientific and Clinical Congress
Patients are more likely to present with regional or distant metastases and experience lower rates of cancer-free survival depending on where they live.
Genetic Data Points to Potential New Therapeutic Target for Adrenocortical Carcinoma
May 29th 2012, 6:28am
AACE Annual Scientific and Clinical Congress
Researchers find that overexpression of a specific gene is associated with poor survival in patients with adrenocortical carcinoma.
Why Medical Tattoos Shouldn't Be Taboo
May 25th 2012, 9:33am
AACE Annual Scientific and Clinical Congress
Another presentation at the AACE meeting on Thursday featured Dr. Saleh Aldasouqi, FACE, ECNU, discussing a topic that is not heard about too often in the medical world: tattoos.
Telemedicine a Valuable Way to Deliver Healthcare
May 24th 2012, 1:21pm
AACE Annual Scientific and Clinical Congress
Patients who live far from medical facilities benefit from having "virtual" conversations with their doctors and are comfortable with that arrangement.
AACE 21st Annual Scientific and Clinical Congress Slideshow
May 24th 2012, 1:20pm
AACE Annual Scientific and Clinical Congress
Photos taken from the AACE 21st Annual Scientific and Clinical Congress held at the Pennsylvania Convention Center, from May 23-27, 2012.
Oncology Posters Presented at Annual Endocrinology Meeting
May 24th 2012, 12:48pm
AACE Annual Scientific and Clinical Congress
A look at two poster presentations from the AACE meeting focusing on insular carcinoma and medullary thyroid cancer.
Dr. Rotkowitz on the Dabrafenib/Trametinib Combination
May 17th 2012, 1:45pm
Dr. Michael Rotkowitz, from Cancer Treatment Centers of America, on the Dabrafenib Plus Trametinib Combination for Melanoma
Neoadjuvant Zytiga Helps Eliminate Some Patients' Prostate Tumors
May 16th 2012, 2:06pm
Combined neoadjuvant treatment with abiraterone acetate (Zytiga) plus standard hormonal therapy before prostatectomy eradicated or nearly eradicated tumors in 34% of patients with localized high-risk prostate cancer.
Combining Two Targeted Therapies Stalls Disease Progression in Melanoma Patients With BRAF Mutations
May 16th 2012, 2:05pm
A combination of the BRAF inhibitor dabrafenib and the MEK inhibitor trametinib has shown promising activity in patients with advanced melanoma.